Sharescart Research Club logo

Key Financials Snapshot

TTM · Standalone · ₹ in Cr
Market Cap
₹7253 Cr.
Stock P/E
47.4
P/B
5.2
Current Price
₹5352
Book Value
₹ 1032.6
Face Value
10
52W High
₹5650
52W Low
₹ 3016.1
Dividend Yield
0%

Kingfa Science Overview

Business

Kingfa Science & Technology (India) Ltd. is engaged in the manufacturing and sale of modified plastic compounds. The company produces a range of engineering plastic compounds, including polypropylenes (PP), nylons (PA), polycarbonates (PC), and blends, which are enhanced with various properties like high strength, heat resistance, flame retardancy, and impact resistance. These specialized compounds serve as critical raw materials for a diverse set of industries. The company makes money by selling these value-added modified plastic compounds to manufacturers across automotive, electrical & electronics, home appliances, construction, medical equipment, and other industrial sectors. It operates as a business-to-business (B2B) supplier.

Revenue Mix

Kingfa India primarily operates within a single business segment: the manufacturing and sale of modified plastic compounds. While it serves a variety of end-user industries (automotive, electrical & electronics, consumer durables, etc.), its revenue is derived from the sales of a unified product category of engineered plastics. Specific revenue contribution percentages from different end-user industries or product types are not typically segmented in its public reporting but are diversified across industrial applications.

Industry

The company operates in the specialty and modified plastics industry in India, which is a sub-segment of the broader plastic products sector. This industry is characterized by high technical requirements, continuous innovation, and strong linkages with other manufacturing sectors. Kingfa India is a subsidiary of Kingfa Science & Technology Co. Ltd., China, which is a global leader in modified plastics. This parentage provides it with a strong competitive standing, leveraging global R&D, technological expertise, and an established reputation in the B2B space. It positions itself as a provider of high-performance and customized plastic solutions, competing with both domestic and international players operating in the Indian market.

MOAT

Kingfa India's primary competitive advantage stems from its association with its parent company, Kingfa Science & Technology Co. Ltd. (China). This provides:

Technological Prowess: Access to the parent's extensive R&D, advanced manufacturing processes, and patented technologies, enabling superior product quality and innovation.

Global Scale & Sourcing: Benefits from the parent's global raw material sourcing network, potentially leading to cost efficiencies and consistent supply.

Brand & Reputation: Leverages the global reputation of the Kingfa brand within the B2B modified plastics segment, instilling confidence in customers regarding product quality and reliability.

Customization Capabilities: Ability to offer highly customized solutions tailored to specific client needs, a critical factor in the specialty plastics market.

Growth Drivers

Growth in End-User Industries: Strong growth in India's automotive, electrical & electronics, consumer durable, and white goods manufacturing sectors drives demand for modified plastics.

Increasing Plastic Penetration: Greater adoption of engineered and modified plastics in new applications and as substitutes for traditional materials (like metal) due to their lightweight, durability, and cost-effectiveness.

'Make in India' Initiative: Government focus on boosting domestic manufacturing can lead to increased demand for locally produced modified plastics.

Technological Advancements: Continuous product innovation and development of higher-performance, eco-friendly, or specialized plastic compounds for niche applications.

Import Substitution: Growing demand for domestically manufactured modified plastics to reduce reliance on imports.

Risks

Raw Material Price Volatility: Key raw materials (polymers, additives) are derivatives of crude oil, making the company susceptible to fluctuations in global crude oil prices and petrochemical markets.

Intense Competition: The modified plastics market in India is competitive, with both domestic and international players vying for market share, potentially impacting pricing power and margins.

Economic Slowdown: A downturn in the broader economy or specific end-user industries (e.g., automotive) can negatively impact demand for its products.

Foreign Exchange Fluctuations: Reliance on imported raw materials or technology can expose the company to adverse movements in foreign currency exchange rates.

Regulatory Changes: Evolving environmental regulations concerning plastic use and disposal could impact operations, product formulations, and compliance costs.

Management & Ownership

Kingfa Science & Technology (India) Ltd. is promoted by Kingfa Science & Technology Co. Ltd. of China, which holds a significant majority stake (typically over 70%). The management team comprises professionals with experience in the specialty chemicals and plastics industry. The strong ownership by a global leader ensures access to best practices, technological guidance, and potentially robust governance standards aligned with its parent company's global operations. The operational management is typically overseen by a mix of local talent and representatives from the parent company, ensuring strategic alignment and technical expertise.

Outlook

Kingfa India is well-positioned to benefit from India's robust manufacturing growth and increasing demand for high-performance engineered plastics. Its strong parentage provides a significant competitive edge in terms of technology, R&D, and quality, allowing it to cater to diverse and demanding industries. The "Make in India" initiative and the ongoing trend of plasticization across various sectors offer substantial growth avenues. However, the company faces inherent risks from volatile raw material prices, intense market competition, and potential slowdowns in key end-user industries. Managing these external factors while leveraging its technological strengths and customization capabilities will be crucial for sustained performance. The outlook remains cautiously optimistic, contingent on economic stability and effective cost management amidst competitive pressures.

Kingfa Science Share Price

Live · BSE / NSE · Inception: 1983
| |
Volume
Price

Key Financials — Profit & Loss

₹ in Cr · Standalone · annual

Kingfa Science Quarterly Results

#(Fig in Cr.) Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Net Sales 394 404 416 418 440 470 462 466 489 578
Other Income 2 2 2 1 5 2 4 3 7 7
Total Income 396 406 418 419 445 471 466 468 497 586
Total Expenditure 357 354 359 362 389 409 404 405 428 497
Operating Profit 39 52 59 57 56 62 62 63 69 88
Interest 1 2 1 1 1 3 1 1 1 1
Depreciation 5 5 5 5 5 6 6 7 7 8
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 32 45 52 50 49 54 54 55 61 80
Provision for Tax 8 12 13 13 15 12 14 14 16 21
Profit After Tax 24 34 39 37 35 42 40 41 45 59
Adjustments -0 -0 0 -0 0 0 0 0 -0 -0
Profit After Adjustments 24 34 39 37 35 42 40 41 45 59
Adjusted Earnings Per Share 20.1 27.7 32.3 30.8 28.6 34.6 32.9 30.4 33.3 43.6

Kingfa Science Profit & Loss

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 219 314 427 602 702 742 627 1048 1404 1488 1745 1995
Other Income 0 1 4 6 4 3 10 1 2 3 9 21
Total Income 219 315 431 607 706 744 638 1049 1406 1491 1754 2017
Total Expenditure 212 288 408 560 666 698 612 966 1276 1303 1520 1734
Operating Profit 7 28 23 47 40 46 26 83 130 188 234 282
Interest 8 7 2 2 2 4 3 5 7 6 7 4
Depreciation 3 3 3 6 8 9 11 13 14 18 22 28
Exceptional Income / Expenses 0 0 0 0 0 0 0 -23 0 0 0 0
Profit Before Tax -5 17 18 39 29 33 12 41 110 164 206 250
Provision for Tax -2 7 5 14 10 9 7 11 28 42 53 65
Profit After Tax -3 11 12 25 19 25 5 31 81 123 153 185
Adjustments 0 0 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments -3 11 12 25 19 25 5 31 81 123 153 185
Adjusted Earnings Per Share -4.4 10.5 12.3 20.3 15.7 20.3 4.4 25.3 67.2 101.2 126.2 140.2

Kingfa Science Balance Sheet

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 8 119 244 305 324 349 354 385 466 589 729
Minority's Interest 0 0 0 0 0 0 0 0 0 0 0
Borrowings 15 16 16 16 17 18 24 17 0 0 0
Other Non-Current Liabilities -4 0 3 5 4 2 8 8 5 4 5
Total Current Liabilities 101 95 142 160 206 227 284 471 539 402 422
Total Liabilities 120 230 405 485 551 596 671 880 1010 994 1156
Fixed Assets 25 29 76 88 85 107 129 126 123 252 244
Other Non-Current Assets 2 43 13 9 94 128 136 142 149 17 58
Total Current Assets 93 158 316 388 372 362 407 612 738 725 854
Total Assets 120 230 405 485 551 596 671 880 1010 994 1156

Kingfa Science Cash Flow

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 0 0 2 1 1 13 2 4 20 -9 0
Cash Flow from Operating Activities -1 19 -119 -116 96 30 -2 38 27 16 60
Cash Flow from Investing Activities -4 -47 -18 -6 -77 -63 -14 -19 -24 2 -30
Cash Flow from Financing Activities 5 34 137 162 -7 22 17 -14 -21 -8 -7
Net Cash Inflow / Outflow 0 6 -1 40 12 -11 1 5 -18 10 23
Closing Cash & Cash Equivalent 0 7 1 41 13 2 4 9 2 0 23

Kingfa Science Ratios

# Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) -4.42 10.45 12.27 20.35 15.73 20.33 4.39 25.29 67.22 101.17 126.22
CEPS(Rs) 0.14 13.29 15.29 25.48 22.35 27.72 13.31 36 78.9 116.35 144.15
DPS(Rs) 0 0 0 0 0 0 0 0 0 10 0
Book NAV/Share(Rs) 11.87 115.56 129.83 252.09 267.94 287.84 292.29 317.57 384.78 486 601.63
Core EBITDA Margin(%) 2.62 7.48 4 6.67 5.02 5.84 2.47 7.82 8.95 12.25 12.75
EBIT Margin(%) 1.39 6.91 4.11 6.58 4.5 4.98 2.42 4.45 8.12 11.24 12.05
Pre Tax Margin(%) -1.9 4.88 3.66 6.25 4.17 4.5 1.89 3.95 7.66 10.87 11.68
PAT Margin (%) -1.23 3.03 2.57 3.99 2.72 3.32 0.85 2.92 5.69 8.11 8.66
Cash Profit Margin (%) 0.04 3.86 3.2 5 3.86 4.53 2.57 4.16 6.68 9.32 9.89
ROA(%) -2.73 6.16 3.91 5.54 3.68 4.29 0.84 3.95 8.61 12.22 14.22
ROE(%) -31.12 16.93 9.9 11.29 6.05 7.31 1.51 8.3 19.14 23.24 23.21
ROCE(%) 4.38 22.47 9.44 13.27 9.46 10.04 3.72 11.02 24.98 30.26 30.7
Receivable days 76.17 72.38 81.19 91.8 101.62 100 118.9 86.17 81.75 92.02 87.92
Inventory Days 40.62 46.79 48.44 54.6 56.83 52.58 73.92 70.35 70.18 64.15 56.18
Payable days 64.19 89.33 98.65 93.42 104.98 115.83 142.35 136.36 147.25 129.81 94.27
PER(x) 0 52.4 62.78 43.25 42.31 18.19 132.75 50.1 19.74 19.38 23.46
Price/Book(x) 19.03 4.74 5.93 3.49 2.48 1.28 2 3.99 3.45 4.03 4.92
Dividend Yield(%) 0 0 0 0 0 0 0 0 0 0.51 0
EV/Net Sales(x) 1.05 1.83 1.68 1.69 1.1 0.63 1.19 1.48 1.15 1.61 2.06
EV/Core EBITDA(x) 35.02 20.89 31.24 21.68 19.43 10.25 28.87 18.66 12.44 12.75 15.36
Net Sales Growth(%) 23.04 43.59 35.95 40.86 16.6 5.7 -15.41 67.07 33.95 5.99 17.27
EBIT Growth(%) 160.19 614.97 -19.23 104.53 -22.23 16.76 -58.91 207.59 149.02 46.23 25.28
PAT Growth(%) 64.11 455 14.85 98.66 -22.67 29.19 -78.38 475.62 165.76 50.5 24.76
EPS Growth(%) 64.11 336.21 17.39 65.86 -22.67 29.19 -78.38 475.62 165.76 50.5 24.76
Debt/Equity(x) 9.24 0.13 0.32 0.07 0.05 0.13 0.19 0.11 0.08 0.05 0.05
Current Ratio(x) 0.92 1.67 2.22 2.43 1.81 1.59 1.43 1.3 1.37 1.8 2.02
Quick Ratio(x) 0.61 1.04 1.74 1.71 1.31 1.1 0.93 0.75 0.83 1.2 1.31
Interest Cover(x) 0.42 3.41 9.17 19.91 13.32 10.4 4.58 8.82 17.79 30.28 31.97
Total Debt/Mcap(x) 0.49 0.03 0.04 0.02 0.02 0.1 0.09 0.03 0.02 0.01 0.01

Growth Rates

Compounded annual
# 1 Year 3 Year 5 Year 10 Year
Sales CAGR +17% +19% +19% +23%
Operating Profit CAGR +24% +41% +38% +42%
PAT CAGR +24% +70% +44%
Share Price CAGR +72% +41% +37% +22%
ROE Average +23% +22% +15% +9%
ROCE Average +31% +29% +20% +15%

Kingfa Science Shareholding Pattern

Latest · Mar 2026
100% held
Promoters 67.02 %
FII 7.76 %
DII (MF + Insurance) 8.85 %
Public (retail) 32.98 %
# Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Promoter 74.9974.9974.9974.9974.9974.9974.9967.0267.0267.02
FII 6.366.336.336.366.356.356.347.787.737.76
DII 0000.0400.170.158.758.758.85
Public 25.0125.0125.0125.0125.0125.0125.0132.9832.9832.98
Others 0000000000
Total 100100100100100100100100100100

Kingfa Science Peer Comparison

Plastic Products Edit Columns

Kingfa Science Quarterly Price

10-year quarterly close · BSE
Show Value Show %

News & Updates

See more…

Kingfa Science Pros & Cons

Pros

  • Company has delivered good profit growth of 43% CAGR over last 5 years
  • Company has a good return on equity (ROE) track record: 3 Years ROE 22%
  • Debtor days have improved from 129.81 to 94.27days.
  • Company is almost debt free.

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend.
  • Stock is trading at 5.2 times its book value.
Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

whatsapp